| Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial J Rosenstock, V Perkovic, OE Johansen, ME Cooper, SE Kahn, N Marx, ... Jama 321 (1), 69-79, 2019 | 1101 | 2019 |
| The role of the immune system in obesity and insulin resistance PS Patel, ED Buras, A Balasubramanyam Journal of obesity 2013 (1), 616193, 2013 | 242 | 2013 |
| Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues L Lin, PK Saha, X Ma, IO Henshaw, L Shao, BHJ Chang, ED Buras, ... Aging cell 10 (6), 996-1010, 2011 | 203 | 2011 |
| Linagliptin effects on heart failure and related outcomes in individuals with type 2 diabetes mellitus at high cardiovascular and renal risk in CARMELINA DK McGuire, JH Alexander, OE Johansen, V Perkovic, J Rosenstock, ... Circulation 139 (3), 351-361, 2019 | 164 | 2019 |
| Hyperglycemia induces oxidative stress and impairs axonal transport rates in mice R Sharma, E Buras, T Terashima, F Serrano, CA Massaad, L Hu, B Bitner, ... PloS one 5 (10), e13463, 2010 | 109 | 2010 |
| Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort N Ajluni, R Meral, AH Neidert, GF Brady, E Buras, B McKenna, F DiPaola, ... Clinical endocrinology 86 (5), 698-707, 2017 | 84 | 2017 |
| Fibro-adipogenic remodeling of the diaphragm in obesity-associated respiratory dysfunction ED Buras, K Converso-Baran, CS Davis, T Akama, F Hikage, DE Michele, ... Diabetes 68 (1), 45-56, 2019 | 76 | 2019 |
| Ghrelin receptor regulates adipose tissue inflammation in aging L Lin, JH Lee, ED Buras, K Yu, R Wang, CW Smith, H Wu, ... Aging (Albany NY) 8 (1), 178, 2016 | 75 | 2016 |
| HIV-1 Vpr induces adipose dysfunction in vivo through reciprocal effects on PPAR/GR co-regulation N Agarwal, D Iyer, SG Patel, RV Sekhar, TM Phillips, U Schubert, T Oplt, ... Science translational medicine 5 (213), 213ra164-213ra164, 2013 | 71 | 2013 |
| Deafness‐related decreases in glycine‐immunoreactive labeling in the rat cochlear nucleus M Asako, AG Holt, RD Griffith, ED Buras, RA Altschuler Journal of neuroscience research 81 (1), 102-109, 2005 | 56 | 2005 |
| Gene therapy with neurogenin 3 and betacellulin reverses major metabolic problems in insulin-deficient diabetic mice V Yechoor, V Liu, A Paul, J Lee, E Buras, K Ozer, S Samson, L Chan Endocrinology 150 (11), 4863-4873, 2009 | 45 | 2009 |
| Changes in glycine immunoreactivity in the rat superior olivary complex following deafness ED Buras, AG Holt, RD Griffith, M Asako, RA Altschuler Journal of Comparative Neurology 494 (1), 179-189, 2006 | 32 | 2006 |
| Mig-6 Plays a Critical Role in the Regulation of Cholesterol Homeostasis and Bile Acid Synthesis BJ Ku, TH Kim, JH Lee, ED Buras, LD White, RD Stevens, OR Ilkayeva, ... Public Library of Science 7 (8), e42915, 2012 | 30 | 2012 |
| The emerging role of interleukin-21 in transplantation A Xie, ED Buras, J Xia, W Chen Journal of clinical & cellular immunology, 1, 2012 | 17 | 2012 |
| Proinsulin-producing, hyperglycemia-induced adipose tissue macrophages underlie insulin resistance in high fat-fed diabetic mice ED Buras, L Yang, P Saha, J Kim, P Mehta, Y Yang, S Hilsenbeck, ... The FASEB Journal 29 (8), 3537, 2015 | 16 | 2015 |
| Spatiotemporal mapping of immune and stem cell dysregulation after volumetric muscle loss JA Larouche, EC Wallace, BD Spence, E Buras, CA Aguilar JCI insight 8 (7), 2023 | 13 | 2023 |
| Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD mice R Li, E Buras, J Lee, R Liu, V Liu, C Espiritu, K Ozer, B Thompson, L Nally, ... Gene therapy 22 (11), 876-882, 2015 | 11 | 2015 |
| Subcutaneous glucagon infusion and continuous glucose monitoring enable effective management of hypoglycemia in a patient with IGF-2-producing hemangiopericytoma ED Buras, E Weatherup, J Wyckoff Clinical Diabetes and Endocrinology 4, 1-6, 2018 | 2 | 2018 |
| Gene Therapy for Type 1 Diabetes: A Combinatorial Approach Using Neurogenin-3-Interleukin-10 Hepatic Gene Transfer Reverses Diabetes in Overtly Diabetic NOD Mice. K Ozer, V Yechoor, E Buras, V Liu, L Chan ENDOCRINE REVIEWS 31 (3), 2010 | 1 | 2010 |
| FRI041 Obesity-associated Diaphragm Weakness Is Not Explained By Defects At The Level Of The Contractile Apparatus RK Verma, D Claflin, C Davis, K Converso-Baran, D Michele, S Brooks, ... Journal of the Endocrine Society 7 (Supplement_1), bvad114. 052, 2023 | | 2023 |
